This article is more than 5 years old. Information may no longer be current.
Top stories in cardiology: FDA expands app’s CVD indications, consequences of skipping breakfast
Among the top stories in cardiology last week were an announcement that the FDA expanded an app’s potential uses in managing CVD, a study that provided new reasons for not missing breakfast and an analysis that showed the American Academy of Pediatrics revising its hypertension guidelines resulted in more children identified as being at risk.
Other popular stories included a report that found a possible heart-healthy benefit for women who frequently donate blood and a study that concluded nearly one in four patients with heart failure were prescribed a medication that might make their condition worse. – by Janel Miller
FDA expands arrhythmia indications for ECG smartphone app
AliveCor announced that its consumer ECG device received two 510(k) clearances by the FDA for its ability to detect bradycardia and tachycardia. Read more.
Skipping breakfast increases CVD mortality risk
Adults who skipped breakfast had a significantly increased risk for CV mortality, according to a study published in the Journal of the American College of Cardiology. Read more.
Newer guidelines identify higher rate of pediatric hypertension
Guidelines implemented by the AAP in 2017 identified more children with adverse metabolic profiles in childhood and elevated CV risk in adulthood compared with the 2004 guidelines, according to findings published in Hypertension. Read more.
Long-term, frequent blood donation may lower CVD odds in women
Women who donated blood frequently over a long period had lower risk for CVD compared with women who infrequently donated blood, according to findings published in Heart. Read more.
Harmful medications prescribed to nearly 25% of patients with heart failure with reduced ejection fraction
Approximately 24% of patients with heart failure and reduced ejection fraction were prescribed a medication that could potentially lead to or worsen heart failure as defined by current guidelines, according to a study published in The American Journal of Cardiology. Read more.